The easy way. Oncologists spoke about methods of combating cervical cancer | Healthy Life | Health

The easy way.  Oncologists spoke about methods of combating cervical cancer |  Healthy Life |  Health

Unfortunately, there are not many types of malignant neoplasms that can be detected at an asymptomatic stage and thereby prevented. But cervical cancer is one of them. Vaccination against HPV and regular visits to the gynecologist can protect women from a tragic outcome and difficult and not always successful treatment.

In 2022, 15,954 new cases of cervical cancer (CC) were identified in Russia, and more than 600 thousand worldwide. At the same time, detection of the disease at the precancerous stage and timely treatment can prevent further development of the pathology and transition to cancer. Key tools for early detection are regular visits to a gynecologist and examination of cervical smears for atypical cells and human papillomavirus (HPV), which, as has long been known, is the main cause of the development of cervical cancer.

How to reduce the incidence

Doctors treating cervical cancer, which often affects very young women, have to contend not only with the malignant process in the patients’ bodies, but also with the lack of knowledge of people who still do not know that cervical cancer today is a completely preventable disease .

Academician of the Russian Academy of Sciences, President of the Russian Society of Obstetricians and Gynecologists Vladimir Serov at a conference dedicated to the fight against this type of cancer, noted that cervical cancer (CC) is one of the most common types of cancer in women, from which 342 thousand women die per year worldwide. “A serious contribution to these sad statistics is made by low awareness in society about precancerous diseases of the cervix, about methods of their prevention and early detection,” Serov emphasized.

Unfortunately, in Russia the incidence of cervical cancer is slightly higher than the world average: 13.8 women per 100 thousand population in the Russian Federation, and 13.3 women per 100 thousand population on average worldwide. The maximum incidence is observed in the Far Eastern (21.56 per 100 thousand population) and Siberian (16.25 per 100 thousand population) Federal Districts.

In just 10 years, this disease has affected almost 190 thousand women, many of them very young: more than half of the cases occur under the age of 39! Our global goal is to bring the incidence rate to 4 per 100 thousand population, that is, to reduce the burden of this cancer tenfold.

Stop at the dysplasia stage

“There has been an almost 100% proven connection between HPV infection and cervical cancer,” he noted in his speech. Vice-President of the Russian Society of Obstetricians and Gynecologists, Head of the Department of Scientific and Educational Programs of the Federal State Budgetary Institution National Medical Research Center of AGP. named after V.I. Kulakov, professor Igor Baranov, — Cervical cancer is a potentially preventable disease. However, this problem is multifaceted and requires a comprehensive solution. Professional training of doctors and medical personnel plays a key role in the early detection and treatment of precancerous conditions of the cervix. Of course, we need extensive educational activities for the population aimed at identifying precancerous changes (dysplasia) and HPV infection.”

The expert’s words are confirmed by a recent study (conducted in January 2024). According to the survey, in our country, only 15% of 1200 respondents named HPV as the main reason for the development of cervical cancer (99.7% of cases of this type of cancer develop against the background of this infection). As a result, more than half of women do not know whether they are carriers of the virus, and a third of women do not regularly visit a doctor for screening.

Detection of precancerous conditions of the cervix at an early stage allows timely treatment to begin using modern methods, as a result of which cancer does not develop. The most common of these conditions is cervical dysplasia, but if detected early, it can be successfully treated.

“In Russia there are effective surgical methods and medications with a targeted effect against precancerous conditions on the cervix with HPV infection,” says Igor Baranov. “Their use helps to successfully cope with dysplasia.”

Only a set of measures will help

Head of the Department of Aesthetic Gynecology and Rehabilitation, Federal State Budgetary Institution National Medical Research Center of AGP named after. V. I. Kulakova, professor Inna Apolikhina emphasized that secondary prevention of cervical cancer, which is based on screening, is not the only way to combat cervical cancer. “The effectiveness of solving this problem lies only in synergy with primary prevention, which includes vaccination against HPV and the elimination of risk factors. Only such measures can save the lives and health of thousands of women.

“In our daily practice, we often see advanced stages of cancer, since a woman does not go to a gynecologist due to the lack of complaints and the asymptomatic course of the disease,” the expert said. “Therefore, the development and implementation of new approaches to CC screening is required, namely the widespread use by women themselves of devices for self-collection of material for HPV diagnosis. It is also necessary to introduce rapid testing methods and develop a national HPV vaccine. In addition, a drug based on diindolylmethane was recently registered in Russia, which has a direct indication for the treatment of cervical dysplasia, as an adjunct to excision. We can learn logistics approaches from the experience of fighting COVID-19. “In addition, increased funding is needed to expand compulsory health insurance programs.”

Experts agreed that to successfully combat cervical cancer, collaboration and partnership are needed between the government, public organizations, the medical community and business. “There is a need for cooperation between the state, public organizations, the medical community and business,” said Professor of the Russian Academy of Sciences, Deputy Director for Science of the State Budgetary Institution of Healthcare of the Moscow Region “MONIIAG” Nina Zarochentseva“This will help develop policies and programs that best reflect the needs and interests of our women in the fight against cervical cancer.”


This news article has been translated from the original language to English by

You can visit the original source at the link below.

Original Source Link